Ingevity director receives 1,904-share stock grant
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Segal Francis David reported acquisition or exercise transactions in this Form 4 filing.
Ingevity Corp director Francis David Segal reported receiving an equity award under the company’s 2025 Omnibus Incentive Plan. He was granted 1,904 shares of Common Stock at no cost, structured as restricted stock units that will vest in full on April 30, 2027. Following this grant, he directly holds 8,284 shares of Ingevity common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,904 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full on April 30, 2027.
Key Figures
Key Terms
restricted stock units financial
2025 Omnibus Incentive Plan financial
Common Stock financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Ingevity (NGVT) disclose in this Form 4?
When do the restricted stock units granted by Ingevity (NGVT) vest?
What plan governs the Ingevity (NGVT) restricted stock unit grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.